MEREO BIOPHARMA (MREO)
(Delayed Data from NSDQ)
$3.26 USD
+0.15 (4.82%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.27 +0.01 (0.31%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth A Momentum F VGM
Brokerage Reports
MEREO BIOPHARMA [MREO]
Reports for Purchase
Showing records 1 - 17 ( 17 total )
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Company: MEREO BIOPHARMA
Industry: Medical - Biomedical and Genetics
Accelerated approval path for NAVI
Provider: TRINITY DELTA
Company: MEREO BIOPHARMA
Industry: Unclassified
Encouraging interim BPS-804 data in OI
Provider: TRINITY DELTA
|